Navigating the Journey in Psoriatic Arthritis: Matching the Right Patient, the Right Drug, and the Right Time

TL;DR

This paper proposes a new approach to managing psoriatic arthritis by matching patients with the best treatments at the right time.

Contribution

It introduces a conceptual journey-based framework for PsA management focusing on patient heterogeneity, treatment options, and timing.

Findings

Current treatments for PsA have improved but many patients still fail to achieve remission.

A journey metaphor is proposed to guide treatment decisions based on patient, drug, and timing factors.

Abstract

Psoriatic arthritis (PsA) is a heterogeneous, immune-mediated disease that significantly impacts quality of life, functional capacity, and healthcare systems. Over the past two decades, treatment options have expanded from conventional therapies to biologic and targeted synthetic DMARDs, enabling more effective disease control. However, many patients still fail to achieve remission or low disease activity (LDA), reflecting challenges in selecting the right treatment at the right time for the right patient. This perspective introduces a conceptual framework for PsA management using the metaphor of a journey, emphasizing three key dimensions: patient heterogeneity (“vehicle”), therapeutic options (“fuel”), and the timing of the intervention (“road”). Aligning these factors can optimize care, reduce disease burden, and improve long-term outcomes.

Figures